Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 21 December 2016
Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant
Press Release, 19 December 2016
Kuros to acquire Xpand in an all-share strategic transaction to create a leading commercial stage orthobiologics company
Press Release, 20 October 2016
Kuros Biosciences' KUR-112 Receives Rare Pediatric Disease Designation
Press Release, 29 September 2016
Kuros Biosciences Reports Financial Results for First Half-Year of 2016
Kuros Interim Results, 2016
English version
Cytos Interim Results, 2015
English version
media-investors
2016